FDA Announces Public Advisory Committee Meeting on Midomafetamine Capsules

Summary

The Food and Drug Administration (FDA) is hosting a public meeting of the Psychopharmacologic Drugs Advisory Committee to provide advice on midomafetamine capsules, a new medication, and is seeking public comments on the matter.